Correlation Between Polydex Pharmaceuticals and Neurobiological Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Polydex Pharmaceuticals and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polydex Pharmaceuticals and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polydex Pharmaceuticals and Neurobiological Technologies, you can compare the effects of market volatilities on Polydex Pharmaceuticals and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polydex Pharmaceuticals with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polydex Pharmaceuticals and Neurobiological Technologies.

Diversification Opportunities for Polydex Pharmaceuticals and Neurobiological Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Polydex and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Polydex Pharmaceuticals and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and Polydex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polydex Pharmaceuticals are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of Polydex Pharmaceuticals i.e., Polydex Pharmaceuticals and Neurobiological Technologies go up and down completely randomly.

Pair Corralation between Polydex Pharmaceuticals and Neurobiological Technologies

If you would invest  0.01  in Neurobiological Technologies on October 7, 2024 and sell it today you would earn a total of  0.00  from holding Neurobiological Technologies or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Polydex Pharmaceuticals  vs.  Neurobiological Technologies

 Performance 
       Timeline  
Polydex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Polydex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Polydex Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.
Neurobiological Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Polydex Pharmaceuticals and Neurobiological Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Polydex Pharmaceuticals and Neurobiological Technologies

The main advantage of trading using opposite Polydex Pharmaceuticals and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polydex Pharmaceuticals position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.
The idea behind Polydex Pharmaceuticals and Neurobiological Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities